AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11886733 — intervention group
Group type: EXPERIMENTAL
Intervention: Overtrained group (10 similar 3 min training sessions during 1 week)
Number of subjects: 35
Study 11886733 — intervention group
Group type: COMPARATOR
Intervention: Control group (no additional training)
Number of subjects: 35
Study 10423050 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-energy helium-neon laser (LEL)
Number of subjects: 30
Study 10423050 — intervention group
Group type: COMPARATOR
Intervention: Placebo light treatment
Number of subjects: 30
Study 7594252 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing intervention to alter the feeding environment
Number of subjects: 0
Study 3236940 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg cinnarizine
Number of subjects: 10
Study 3236940 — intervention group
Group type: COMPARATOR
Intervention: 75 mg diphenhydramine
Number of subjects: 10
Study 3236940 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 28637262 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive anti‐smoking counseling
Number of subjects: 23
Study 28637262 — intervention group
Group type: COMPARATOR
Intervention: Counseling and nicotine replacement therapy
Number of subjects: 23
Study 28209740 — intervention group
Group type: EXPERIMENTAL
Intervention: Head-down tilt (HDT) with ambient air
Number of subjects: 6
Study 28209740 — intervention group
Group type: EXPERIMENTAL
Intervention: Head-down tilt (HDT) with 0.5% CO2
Number of subjects: 6
Study 28209740 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to 3% CO2 after HDT (ambient air)
Number of subjects: 6
Study 25613907 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 92
Study 25613907 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 92
Study 23373742 — intervention group
Group type: EXPERIMENTAL
Intervention: Classroom presentation by older-peer educators
Number of subjects: 1120
Study 23373742 — intervention group
Group type: EXPERIMENTAL
Intervention: Classroom presentation by health professionals
Number of subjects: 1120
Study 23373742 — intervention group
Group type: EXPERIMENTAL
Intervention: Exploration of a museum exhibition
Number of subjects: 1120
Study 23373742 — intervention group
Group type: EXPERIMENTAL
Intervention: Exploration of an internet-based virtual museum
Number of subjects: 1120
Study 23373742 — intervention group
Group type: COMPARATOR
Intervention: No intervention (comparison group)
Number of subjects: 1120
Study 21062997 — intervention group
Group type: COMPARATOR
Intervention: MPG 0/1 group
Number of subjects: 139
Study 21062997 — intervention group
Group type: EXPERIMENTAL
Intervention: MPG 2/3 group
Number of subjects: 139
Study 18294324 — intervention group
Group type: EXPERIMENTAL
Intervention: Published RaCTs
Number of subjects: 116
Study 18294324 — intervention group
Group type: COMPARATOR
Intervention: Unpublished RaCTs
Number of subjects: 116
Study 20512273 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural fentanyl (100 microg)
Number of subjects: 29
Study 20512273 — intervention group
Group type: COMPARATOR
Intervention: Intravenous fentanyl (100 microg)
Number of subjects: 29
Study 16281143 — intervention group
Group type: EXPERIMENTAL
Intervention: XCF‐Q160AW prototype colonoscope
Number of subjects: 280
Study 16281143 — intervention group
Group type: COMPARATOR
Intervention: Standard colonoscope (Olympus 140 series)
Number of subjects: 280
Study 12182982 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Accelerated Hyperfractionated (CAHF) radiotherapy at 1.5 Gy/fraction b.i.d. (6‐h interval), 5 d/wk, total dose 66 Gy in 44 fractions during 4.4 weeks
Number of subjects: 101
Study 12182982 — intervention group
Group type: COMPARATOR
Intervention: Late-course Accelerated Hyperfractionated (LCAF) radiotherapy, conventional fractionation at 1.8 Gy/fraction to 41.4 Gy in 23 fractions during 4.6 weeks, followed by accelerated fractionation RT at 1.5 Gy/fraction
Number of subjects: 101
Study 9630269 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-D phase contrast (PC) magnetic resonance angiography (MRA)
Number of subjects: 22
Study 9630269 — intervention group
Group type: COMPARATOR
Intervention: Digital subtraction angiography (DSA)
Number of subjects: 22
Study 7943791 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast injection rate (0.5 mL/s) of 0.3% hypobaric bupivacaine
Number of subjects: 18
Study 7943791 — intervention group
Group type: COMPARATOR
Intervention: Slow injection rate (0.02 mL/s) of 0.3% hypobaric bupivacaine
Number of subjects: 18
Study 3129589 — intervention group
Group type: EXPERIMENTAL
Intervention: Weighted nasoenteric feeding tubes
Number of subjects: 116
Study 3129589 — intervention group
Group type: COMPARATOR
Intervention: Unweighted nasoenteric feeding tubes
Number of subjects: 116
Study 11590524 — intervention group
Group type: EXPERIMENTAL
Intervention: Nelfinavir-containing therapy (PI treatment)
Number of subjects: 120
Study 11590524 — intervention group
Group type: COMPARATOR
Intervention: RTI therapy alone
Number of subjects: 120
Study 31517324 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet plus nutritional orientation (DIET group, n=20)
Number of subjects: 40
Study 31517324 — intervention group
Group type: COMPARATOR
Intervention: Only nutritional orientation (Control group, n=20)
Number of subjects: 40
Study 30342539 — intervention group
Group type: EXPERIMENTAL
Intervention: Movement through Active Personalised engagement programme (intervention group)
Number of subjects: 338
Study 30342539 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 338
Study 26820612 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-Visit Prioritization intervention
Number of subjects: 2496
Study 26820612 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 2496
Study 25099924 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (SNP) administered by continuous infusion and titrated to maintain BP control
Number of subjects: 153
Study 25099924 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (SNP) administered by continuous infusion
Number of subjects: 153
Study 21745028 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intervention (motivational and volitional components)
Number of subjects: 35
Study 21745028 — intervention group
Group type: COMPARATOR
Intervention: Motivation first intervention
Number of subjects: 35
Study 21745028 — intervention group
Group type: COMPARATOR
Intervention: Volition first intervention
Number of subjects: 35
Study 21745028 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intervention
Number of subjects: 35
Study 20353588 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoprostenol infusion for 24 hours
Number of subjects: 14
Study 20353588 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion for 24 hours
Number of subjects: 14
Study 18029928 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided fine-needle aspiration biopsy
Number of subjects: 6
Study 18029928 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided core needle biopsy
Number of subjects: 6
Study 18029928 — intervention group
Group type: EXPERIMENTAL
Intervention: Total thyroidectomy
Number of subjects: 6
Study 18029928 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy with or without radiotherapy
Number of subjects: 6
Study 15620484 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuflex metacarpophalangeal joint replacement
Number of subjects: 22
Study 15620484 — intervention group
Group type: COMPARATOR
Intervention: Swanson metacarpophalangeal joint replacement
Number of subjects: 22
Study 15620484 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuflex and Swanson metacarpophalangeal joint replacements
Number of subjects: 22
Study 11802252 — intervention group
Group type: EXPERIMENTAL
Intervention: CPX (8‐cyclopentyl‐1,3‐dipropylxanthine)
Number of subjects: 37
Study 10459114 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal phototoxic doses (MPD)
Number of subjects: 31
Study 10459114 — intervention group
Group type: COMPARATOR
Intervention: Two thirds of the MPD
Number of subjects: 31
Study 10459114 — intervention group
Group type: COMPARATOR
Intervention: One half of the MPD
Number of subjects: 31
Study 8546293 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron 0.1 mg.kg‐1
Number of subjects: 60
Study 8546293 — intervention group
Group type: COMPARATOR
Intervention: droperidol 75 micrograms.kg‐1
Number of subjects: 60
Study 8546293 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 60
Study 2678331 — intervention group
Group type: EXPERIMENTAL
Intervention: GE-0943 6000 units
Number of subjects: 154
Study 2678331 — intervention group
Group type: EXPERIMENTAL
Intervention: GE-0943 3000 units
Number of subjects: 154
Study 2678331 — intervention group
Group type: COMPARATOR
Intervention: Urokinase
Number of subjects: 154
Study 817761 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose intravesical thiotepa administered immediately after cystodiathermy
Number of subjects: 0
Study 817761 — intervention group
Group type: COMPARATOR
Intervention: Cystodiathermy alone (Control)
Number of subjects: 0
Study 817761 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose intravesical thiotepa
Number of subjects: 0
Study 817761 — intervention group
Group type: EXPERIMENTAL
Intervention: Continued use of adjuvant thiotepa after recurrent tumor
Number of subjects: 0
Study 31236889 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 66
Study 31236889 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo needle puncture)
Number of subjects: 66
Study 28802816 — intervention group
Group type: EXPERIMENTAL
Intervention: grazoprevir (100 mg/day) plus ruzasvir (60 mg/day) plus uprifosbuvir (450 mg/day)
Number of subjects: 241
Study 28802816 — intervention group
Group type: EXPERIMENTAL
Intervention: grazoprevir (100 mg/day) plus ruzasvir (60 mg/day) plus uprifosbuvir (300 mg/day)
Number of subjects: 241
Study 28802816 — intervention group
Group type: EXPERIMENTAL
Intervention: grazoprevir (100 mg/day) plus elbasvir (50 mg/day) plus uprifosbuvir (300 mg/day)
Number of subjects: 241
Study 28802816 — intervention group
Group type: EXPERIMENTAL
Intervention: grazoprevir (100 mg/day) plus elbasvir (50 mg/day) plus uprifosbuvir (450 mg/day)
Number of subjects: 241
Study 28802816 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall adverse events
Number of subjects: 241
Study 25290658 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Cognitive‐Behavioral Therapy
Number of subjects: 214
Study 25290658 — intervention group
Group type: COMPARATOR
Intervention: Twelve‐Step Facilitation Therapy
Number of subjects: 214
Study 23948313 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based intervention with specific factors for children and parents exposed to IPV
Number of subjects: 155
Study 23948313 — intervention group
Group type: COMPARATOR
Intervention: Control intervention based on non-specific factors
Number of subjects: 155
Study 23948313 — intervention group
Group type: COMPARATOR
Intervention: Both interventions (specific factors and control)
Number of subjects: 155
Study 23948313 — intervention group
Group type: COMPARATOR
Intervention: Children in both interventions
Number of subjects: 155
Study 23948313 — intervention group
Group type: COMPARATOR
Intervention: Teachers reported
Number of subjects: 155
Study 23948313 — intervention group
Group type: COMPARATOR
Intervention: Higher treatment adherence in both programs
Number of subjects: 155
Study 22200721 — intervention group
Group type: EXPERIMENTAL
Intervention: Shenfu Injection (SHF) pre-treatment group
Number of subjects: 133
Study 22200721 — intervention group
Group type: EXPERIMENTAL
Intervention: Shenfu Injection (SHF) post-treatment group
Number of subjects: 133
Study 22200721 — intervention group
Group type: COMPARATOR
Intervention: Control group (no SHF)
Number of subjects: 133
Study 19850330 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextroscope preoperative plans
Number of subjects: 84
Study 19850330 — intervention group
Group type: COMPARATOR
Intervention: Control group (no Dextroscope plans)
Number of subjects: 84
Study 16710947 — intervention group
Group type: EXPERIMENTAL
Intervention: Test mask (TST) with three valves and a reservoir designed to deliver up to 80% oxygen
Number of subjects: 31
Study 16710947 — intervention group
Group type: COMPARATOR
Intervention: Basic mask (BAS) without valves or oxygen reservoir bag
Number of subjects: 31
Study 16710947 — intervention group
Group type: EXPERIMENTAL
Intervention: Test mask (TST)
Number of subjects: 31
Study 16710947 — intervention group
Group type: COMPARATOR
Intervention: Basic mask (BAS)
Number of subjects: 31
Study 12627928 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefepime 2 g intravenously every 12 hours
Number of subjects: 7
Study 10816399 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril renography (25 mg oral dose)
Number of subjects: 43
Study 10816399 — intervention group
Group type: COMPARATOR
Intervention: Gadolinium-enhanced MR angiography
Number of subjects: 43
Study 8848922 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia with 0.5% hyperbaric bupivacaine
Number of subjects: 433
Study 8848922 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia with thiopentone, fentanyl, atracurium, nitrous oxide, and isoflurane
Number of subjects: 433
Study 8848922 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia in patients aged 20-60 years
Number of subjects: 433
Study 8848922 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia in men
Number of subjects: 433
Study 8848922 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia in women
Number of subjects: 433
Study 1813703 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep level of anesthesia
Number of subjects: 0
Study 1813703 — intervention group
Group type: COMPARATOR
Intervention: Standard anesthesia
Number of subjects: 0
Study 6151528 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg b.d.
Number of subjects: 80
Study 6151528 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 mg b.d.
Number of subjects: 80
Study 30850461 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person tutorial with a research assistant
Number of subjects: 93
Study 30850461 — intervention group
Group type: EXPERIMENTAL
Intervention: Link to view videos on their own
Number of subjects: 93
Study 30850461 — intervention group
Group type: COMPARATOR
Intervention: Usual care comparison group
Number of subjects: 93
Study 30850461 — intervention group
Group type: EXPERIMENTAL
Intervention: Both training modalities (in-person and video)
Number of subjects: 93
Study 30166846 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete caries removal (CCR)
Number of subjects: 143
Study 30166846 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial caries removal (PCR)
Number of subjects: 143
Study 30166846 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 143
Study 27270643 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 2 Diabetes (T2DM) patients with more than 60 months duration
Number of subjects: 406
Study 27270643 — intervention group
Group type: COMPARATOR
Intervention: Hypertensive patients
Number of subjects: 406
Study 27270643 — intervention group
Group type: COMPARATOR
Intervention: Healthy individuals
Number of subjects: 406
Study 23213050 — intervention group
Group type: EXPERIMENTAL
Intervention: Tier 2 small‐group tutoring in reading for 14 weeks
Number of subjects: 134
Study 22948497 — intervention group
Group type: EXPERIMENTAL
Intervention: onabotulinumtoxinA
Number of subjects: 170
Study 22948497 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 170
Study 20626264 — intervention group
Group type: EXPERIMENTAL
Intervention: LEDT treatment
Number of subjects: 17
Study 20626264 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 17
Study 17560768 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxapram
Number of subjects: 13
Study 17560768 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 13
Study 16003618 — intervention group
Group type: EXPERIMENTAL
Intervention: Sterile gloves
Number of subjects: 269
Study 16003618 — intervention group
Group type: COMPARATOR
Intervention: Clean nonsterile gloves
Number of subjects: 269
Study 11938608 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting position
Number of subjects: 6
Study 11938608 — intervention group
Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 6
Study 9566827 — intervention group
Group type: EXPERIMENTAL
Intervention: Euglycemic hyperinsulinemic clamping (HI; plasma insulin at 150 mU/l, glucose at 4‐5 mmol/l)
Number of subjects: 9
Study 9566827 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperglycemic hyperinsulinemic clamping (HG; plasma glucose at 15 mmol/l)
Number of subjects: 9
Study 9566827 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion (control)
Number of subjects: 9
Study 7995828 — intervention group
Group type: EXPERIMENTAL
Intervention: Triiodothyronine (0.15 microgram/kg bolus infusion after aortic cross-clamp removal; 0.1 microgram/kg before end of CPB; 0.1 microgram/kg at 4, 9, and 14 hours after CPB)
Number of subjects: 30
Study 7995828 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 30
Study 2484510 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenite, 200 micrograms daily
Number of subjects: 139
Study 2484510 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenate, 200 micrograms daily
Number of subjects: 139
Study 2484510 — intervention group
Group type: EXPERIMENTAL
Intervention: L-selenomethionine, 200 micrograms daily
Number of subjects: 139
Study 2484510 — intervention group
Group type: EXPERIMENTAL
Intervention: High selenium yeast, 200 micrograms daily
Number of subjects: 139
Study 2484510 — intervention group
Group type: EXPERIMENTAL
Intervention: Inorganic selenium compounds (selenite, selenate)
Number of subjects: 139
Study 31888682 — intervention group
Group type: EXPERIMENTAL
Intervention: Short cast (below-elbow)
Number of subjects: 74
Study 31888682 — intervention group
Group type: COMPARATOR
Intervention: Long cast (above-elbow)
Number of subjects: 74
Study 28329131 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline (200 mg/day, once daily)
Number of subjects: 154
Study 28329131 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy (CBT)
Number of subjects: 154
Study 28329131 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 154
Study 26518597 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone psycho-education by a midwife
Number of subjects: 339
Study 26518597 — intervention group
Group type: COMPARATOR
Intervention: Usual maternity care
Number of subjects: 339
Study 22539817 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin/Ezetimibe 10/10 mg
Number of subjects: 153
Study 22539817 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg
Number of subjects: 153
Study 22539817 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10 mg
Number of subjects: 153
Study 22548691 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmaceutical care provided by specially trained pharmacists
Number of subjects: 714
Study 22548691 — intervention group
Group type: COMPARATOR
Intervention: Usual care (routine dispensing counseling)
Number of subjects: 714
Study 19301727 — intervention group
Group type: EXPERIMENTAL
Intervention: Loratadine
Number of subjects: 90
Study 19301727 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketotifen
Number of subjects: 90
Study 19301727 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 17717224 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial neuromuscular block (50% depression of the first twitch)
Number of subjects: 20
Study 17717224 — intervention group
Group type: EXPERIMENTAL
Intervention: Profound neuromuscular block (95% depression of the first twitch)
Number of subjects: 20
Study 17717224 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine reversal after profound NMB
Number of subjects: 20
Study 17717224 — intervention group
Group type: COMPARATOR
Intervention: Baseline measurement (control)
Number of subjects: 20
Study 17717224 — intervention group
Group type: EXPERIMENTAL
Intervention: Noxious tetanic electrical stimulation
Number of subjects: 20
Study 15031786 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate (tenofovir DF)
Number of subjects: 16
Study 15031786 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 15031786 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamivudine
Number of subjects: 16
Study 15031786 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamivudine and tenofovir DF
Number of subjects: 16
Study 16201191 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term antimicrobial prophylaxis (24 hours)
Number of subjects: 731
Study 16201191 — intervention group
Group type: COMPARATOR
Intervention: Long-term antimicrobial prophylaxis (72 hours)
Number of subjects: 731
Study 9443517 — intervention group
Group type: EXPERIMENTAL
Intervention: High oral dose of D-amphetamine
Number of subjects: 0
Study 9443517 — intervention group
Group type: EXPERIMENTAL
Intervention: Low oral dose of D-amphetamine
Number of subjects: 0
Study 9443517 — intervention group
Group type: COMPARATOR
Intervention: Control (no amphetamine)
Number of subjects: 0
Study 7944039 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy
Number of subjects: 175
Study 2465437 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketanserin (40 mg every 12 h)
Number of subjects: 12
Study 2465437 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 2196193 — intervention group
Group type: EXPERIMENTAL
Intervention: Glipizide 15 mg daily
Number of subjects: 9
Study 2196193 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 2196193 — intervention group
Group type: EXPERIMENTAL
Intervention: Glipizide
Number of subjects: 9
Study 4569248 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis (4% Delta(1)-tetrahydrocannabinol) administered orally in doses of 8, 12, and 16 milligrams
Number of subjects: 0
Study 4569248 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (70 grams) administered orally
Number of subjects: 0
Study 31606826 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening using FRAX®
Number of subjects: 12483
Study 31606826 — intervention group
Group type: COMPARATOR
Intervention: Usual NHS care (Control)
Number of subjects: 12483